Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ENROLLING BY INVITATION
NCT06777173
NA

Clinical Study of Antiviral Therapy Combined With Novel Immunotherapy for CHB in Adults

Sponsor: Beijing Ditan Hospital

View on ClinicalTrials.gov

Summary

Establish a study cohort of adult chronic hepatitis B antiviral treatment based on the principle of responseguidedtreatment (RGT) corresponding to the child cohort, analyze the clinical cure factors of IC and IT stage adults chronic hepatitis B, and optimize the antiviral treatment plan. To determine the safety and efficacy of PD-1 antibody combined with Peg-FNa-2b in the treatment of adult NAs patients with CHB advantage.

Official title: Clinical Study of Antiviral Therapy Combined With Novel Immunotherapy for Chronic Hepatitis B in Adults

Key Details

Gender

FEMALE

Age Range

18 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

180

Start Date

2023-12-01

Completion Date

2026-11-01

Last Updated

2025-01-15

Healthy Volunteers

No

Interventions

DRUG

Peg interferon alfa-2b

NA combined with Peg interferon alfa-2b

Locations (1)

Beijing Ditan hospital

Beijing, China